INTEGRATING CLINICAL PHARMACOLOGY AND HOSPITAL PHARMACY IN ONCOLOGY: ADVANCES IN CHEMOTHERAPY, TARGETED THERAPY AND ANTICANCER DRUG DEVELOPMENT

Abstract

Cancer continues to be a leading cause of mortality worldwide, underscoring the need for more effective therapeutic strategies. Recent advances in chemotherapy, targeted therapy, and clinical pharmacology have substantially enhanced treatment outcomes and safety profiles. A comprehensive understanding of pharmacokinetics, pharmacodynamics, drug–drug interactions, and metabolism of anticancer agents is critical for optimizing therapeutic regimens and reducing toxicity. The integration of pharmacogenomic and molecular data into clinical decision-making represents a key direction in modern oncology and chemotherapy, facilitating the implementation of personalized medicine and improving patient quality of life